Surmodics, Inc. products

The Vetex Medical ReVene^®  Thrombectomy Catheter has been engineered with a patented dynamic cage technology that enables the predictable removal of wall adherent thrombus in a single session without the need for thrombolytics.

Ara h 2 consists of two isoforms, called Ara h 2.0101 and Ara h 2.0201. The second isoform contains other IgE epitopes and has similar but higher IgE binding than Ara h 2.0101 (81% vs. 77%) . Ara h 2.0201, generally known as the most important peanut allergen, is a conglutin storage protein and accounts together with Ara h 6.0101 for the majority of the IgE immune response. DIARECT™ antigens are for further manufacturing or research use only.

The Surmodics low-particulate lubricious coatings have a proven track record, meeting the demanding regulatory requirements in all clinical segments: coronary, peripheral, neurovascular, and structural heart devices. Our covalently bound family of Hydrophilic Coating formulations demonstrate markedly superior lubricity and tracking, durability, and particulate reduction.

The exceptional performance of Surmodics active (heparin) and passive (non-heparin) hemocompatible coatings begins with our proprietary PhotoLink™ UV curing process, which uses light-activated chemistry to bond coatings quickly and evenly to nearly all medical-grade materials. Our rigorous testing and extensive experience with hemocompatible coatings helps smooth the path to regulatory approval.

The Surmodics drug-delivery coatings utilize innovative technology to meet a variety of clinical needs – from short-term to long-term controlled release – and across a range of compounds including small molecules and antibiotics. Our unique Bravo™ durable drug-delivery polymer system is designed for site-specific delivery and stability of low molecular weight drugs.